Forbes J M & Co. LLP Acquires 352 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Forbes J M & Co. LLP raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,262 shares of the financial services provider’s stock after buying an additional 352 shares during the period. Forbes J M & Co. LLP’s holdings in iShares Biotechnology ETF were worth $5,455,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Park Avenue Securities LLC purchased a new stake in iShares Biotechnology ETF in the third quarter worth $218,000. Albion Financial Group UT raised its holdings in iShares Biotechnology ETF by 0.3% in the 3rd quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock worth $18,925,000 after purchasing an additional 356 shares in the last quarter. Valeo Financial Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth about $206,000. CenterStar Asset Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $386,000. Finally, Martin Capital Advisors LLP increased its position in shares of iShares Biotechnology ETF by 1.0% during the third quarter. Martin Capital Advisors LLP now owns 13,169 shares of the financial services provider’s stock valued at $1,918,000 after buying an additional 133 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $137.67 on Friday. The company has a 50-day simple moving average of $136.22 and a two-hundred day simple moving average of $141.41. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.